Expertise in
5
conditions

Wen-nan T. Huang

Taitung, TNQ, TW 
Expertise in
5
conditions
Taitung, TNQ, TW 

Overview

Wen-nan Huang practices practicing medicine in Taitung, Taiwan.

Huang is highly rated in 5 conditions, according to our data. Their clinical expertise encompasses Systemic Lupus Erythematosus (SLE), Lupus Nephritis, Ankylosing Spondylitis, and Arthritis.

They are actively involved in clinical research, co-authoring 79 peer reviewed articles and participating in 3 clinical trials.

Locations

Taitung, TNQ, Taiwan
Other Locations
TPQ, Taiwan
Kaohsiung, KHQ, Taiwan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of LY3471851 (NKTR-358) in Adults With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of LY3471851 (NKTR-358) in Adults With Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: April 23, 2024
Intervention Type: Drug
Study Drug: LY3471851
Study Phase: Phase 2
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: January 30, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
View 2 Less Clinical Trials

79 Total Publications

Achieving Targeted Combined Endpoints in Patients With Atopic Dermatitis: A Real-World Study.
Achieving Targeted Combined Endpoints in Patients With Atopic Dermatitis: A Real-World Study.
Journal: The Journal of dermatology
Published: April 14, 2026

Frequently Asked Questions about Wen-nan T. Huang

Is Wen-nan T. Huang a top-rated expert for Systemic Lupus Erythematosus (SLE)?

MediFind is an objective health platform that identifies experts based on real-world data. Wen-nan T. Huang is classified as an Advanced expert for Systemic Lupus Erythematosus (SLE), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Wen-nan T. Huang participate in research or clinical trials?

Yes. Wen-nan T. Huang has published 79 articles and abstracts on conditions like Systemic Lupus Erythematosus (SLE). You can view a list of Wen-nan T. Huang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Huang's expertise for a condition
ConditionClose
      View All 20 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile